After being rejected by the US, J&J looking to Europe. Doctors say demand for such a drug would be strong because about 20 percent to 30 percent of men lack control over ejaculation and reach climax sooner than they would like. While hardly a life-threatening disease, premature ejaculation can cause emotional distress for men and their partners.
